formatoriginal-regeneron
Formatoriginal / Shutterstock.com
28 October 2021Alex Baldwin

Regeneron convinces PTAB to review Novartis syringe patent

The  US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant  Regeneron.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
19 November 2026   The seven-partner team are some of the “most accomplished” IP trial lawyers in the country, bringing extensive experience in patent, trade secret and commercial disputes for major technology and life sciences companies.
Careers
19 November 2026   The leadership change marks the end of Bradley’s 15-year tenure at BMS, during which she also served as INTA president for one year.
Regulation & Industry
19 November 2026   The 2027 US awards in Boston features three new categories recognising AI innovation, in-house IP teams and cross-border patent litigation.